|
Name |
Cerevisterol
|
Molecular Formula | C28H46O3 | |
IUPAC Name* |
(3S,5R,6R,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5,6-triol
|
|
SMILES |
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=C[C@H]([C@@]4([C@@]3(CC[C@@H](C4)O)C)O)O)C
|
|
InChI |
InChI=1S/C28H46O3/c1-17(2)18(3)7-8-19(4)22-9-10-23-21-15-25(30)28(31)16-20(29)11-14-27(28,6)24(21)12-13-26(22,23)5/h7-8,15,17-20,22-25,29-31H,9-14,16H2,1-6H3/b8-7+/t18-,19+,20-,22+,23-,24-,25+,26+,27+,28-/m0/s1
|
|
InChIKey |
ARXHRTZAVQOQEU-BRVLHLJYSA-N
|
|
Synonyms |
Cerevisterol; Cerevisterin; 516-37-0; 6MHQ9J8E6J; CHEBI:68083; (3S,5R,6R,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5,6-triol; Ergosta-7,22-diene-3,5,6-triol, (3beta,5alpha,6beta,22E)-; Ergosta-7,22-diene-3beta,5alpha,6beta-triol; UNII-6MHQ9J8E6J; CHEMBL491546; SCHEMBL3277925; DTXSID001045318; HY-N3571; MFCD08274564; ZINC43620416; CS-0023859; Ergosta-7,22E-diene-3beta,5alpha,6beta-triol; 5alpha-Ergosta-7,22-diene-3beta,5,6beta-triol; (22E)-ergosta-7,22-diene-3beta,5alpha,6beta-triol; Q15410887; (3beta,5alpha,6beta,22E)-Ergosta-7,22-diene-3,5,6-triol
|
|
CAS | 516-37-0 | |
PubChem CID | 10181133 | |
ChEMBL ID | CHEMBL491546 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 430.7 | ALogp: | 5.6 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 60.7 | Aromatic Rings: | 4 |
Heavy Atoms: | 31 | QED Weighted: | 0.502 |
Caco-2 Permeability: | -4.804 | MDCK Permeability: | 0.00004270 |
Pgp-inhibitor: | 0.02 | Pgp-substrate: | 0.985 |
Human Intestinal Absorption (HIA): | 0.099 | 20% Bioavailability (F20%): | 0.966 |
30% Bioavailability (F30%): | 0.755 |
Blood-Brain-Barrier Penetration (BBB): | 0.023 | Plasma Protein Binding (PPB): | 86.20% |
Volume Distribution (VD): | 1.099 | Fu: | 1.81% |
CYP1A2-inhibitor: | 0.053 | CYP1A2-substrate: | 0.472 |
CYP2C19-inhibitor: | 0.045 | CYP2C19-substrate: | 0.848 |
CYP2C9-inhibitor: | 0.25 | CYP2C9-substrate: | 0.112 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.12 |
CYP3A4-inhibitor: | 0.811 | CYP3A4-substrate: | 0.66 |
Clearance (CL): | 1.913 | Half-life (T1/2): | 0.142 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.082 |
Drug-inuced Liver Injury (DILI): | 0.043 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.911 | Maximum Recommended Daily Dose: | 0.97 |
Skin Sensitization: | 0.047 | Carcinogencity: | 0.003 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.136 |
Respiratory Toxicity: | 0.957 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004757 | 1.000 | D0G8OC | 0.491 | ||||
ENC004804 | 1.000 | D0G5CF | 0.469 | ||||
ENC006034 | 0.777 | D06JPB | 0.451 | ||||
ENC003121 | 0.777 | D0N1TP | 0.383 | ||||
ENC004735 | 0.657 | D01QUS | 0.369 | ||||
ENC001092 | 0.640 | D0Y7LD | 0.369 | ||||
ENC005707 | 0.640 | D08SVH | 0.339 | ||||
ENC004738 | 0.640 | D03ZTE | 0.309 | ||||
ENC002327 | 0.615 | D0G3SH | 0.309 | ||||
ENC002206 | 0.594 | D0M4WA | 0.307 |